Clinical trial

A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium

NCT00469768 · International Partnership for Microbicides, Inc., Industry · Completed

Key facts

NCT number NCT00469768
Title A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium
Official title A Double-blind, Randomized, Placebo-controlled Safety and Pharmacokinetic Study in Healthy HIV-negative Women to Assess the Delivery of Dapivirine From Matrix and Reservoir Intravaginal Rings Each Containing 25 mg of Dapivirine
Lead sponsor International Partnership for Microbicides, Inc., Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions HIV Infections
Intervention type Drug, Other
Interventions dapivirine reservoir intravaginal ring, dapivirine matrix intravaginal ring, placebo intravaginal ring
Enrollment 24
Start date May 1, 2007
Completion Aug 1, 2007
First posted May 4, 2007
Last update posted Sep 1, 2009
Countries Belgium

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies